Vasotec and Urinary frequency aggravated - a phase IV clinical study of FDA data

Summary:

Urinary frequency aggravated is reported as a side effect among people who take Vasotec (enalapril maleate), especially for people who are male, 60+ old, also take Coumadin,.

The phase IV clinical study analyzes which people have Urinary frequency aggravated when taking Vasotec. It is created by eHealthMe based on reports of 14,393 people who have side effects when taking Vasotec from the FDA, and is updated regularly.

What is Vasotec?

Vasotec has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 14,646 Vasotec users. Check the latest studies of Vasotec.

What is Urinary frequency aggravated?

Urinary frequency aggravated is found to be associated with 315 drugs and 54 conditions by eHealthMe. Check the latest studies of Urinary frequency aggravated.



On Jul, 18, 2026

14,393 people reported to have side effects when taking Vasotec.
Among them, 37 people (0.26%) have Urinary frequency aggravated.

Could Vasotec cause Urinary frequency aggravated?

Among these 37 people:

What is the gender of people who have Urinary frequency aggravated when taking Vasotec? *

  • female: 27.03 %
  • male: 72.97 %

What is the age of people who have Urinary frequency aggravated when taking Vasotec? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.78 %
  • 40-49: 13.89 %
  • 50-59: 25.0 %
  • 60+: 58.33 %

What are other drugs people take besides Vasotec? *

  1. Lipitor: 8 people, 21.62%
  2. Coumadin: 8 people, 21.62%
  3. Alprazolam: 6 people, 16.22%
  4. Restoril: 6 people, 16.22%
  5. Leucovorin Calcium: 6 people, 16.22%
  6. Cipro: 6 people, 16.22%
  7. Acetaminophen: 5 people, 13.51%
  8. Tylenol W/ Codeine No. 3: 5 people, 13.51%
  9. Norvasc: 5 people, 13.51%
  10. Rezulin: 5 people, 13.51%

What are other side effects people have besides Urinary frequency aggravated? *

  1. Weakness: 10 people, 27.03%
  2. Blood Urea Increased: 9 people, 24.32%
  3. Urination - Painful: 8 people, 21.62%
  4. Malaise (a feeling of general discomfort or uneasiness): 8 people, 21.62%
  5. Fatigue (feeling of tiredness): 8 people, 21.62%
  6. Paleness (unusual lightness of skin colour): 7 people, 18.92%
  7. Oedema Peripheral (superficial swelling): 6 people, 16.22%
  8. Blood Creatinine Increased: 6 people, 16.22%
  9. Haematuria Present (presence of blood in urine due to trauma): 5 people, 13.51%
  10. Fever: 5 people, 13.51%

* Approximation only. Some reports may have incomplete information.

Do you take Vasotec and have Urinary frequency aggravated?

- Check whether Urinary frequency aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vasotec:

Urinary frequency aggravated treatments and more:

How severe was Urinary frequency aggravated and when was it recovered:

Expand to all the drugs that have ingredients of enalapril maleate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vasotec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary frequency aggravated:

Browse all the conditions that are associated with Urinary frequency aggravated:


How the study uses the data?

The study uses data from the FDA. It is based on enalapril maleate (the active ingredients of Vasotec) and Vasotec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: